Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of MedImmune by AstraZeneca PLC pursuant to a...
Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that the company was...
- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program...
GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the ninth consecutive year. The Technology Fast 50 is a...
Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/ -- Standard & Poor's will make its semi-annual changes...
Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Data presented today from a Phase 3...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 156 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 260 | -4.65 | -71.5384615385 | 6.5 | 6.5 | 0.26 | 2456 | 1.14091857 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
